The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Open accessAbstract
The spontaneous deamination of cytosine is a major source of transitions from C•G to T•A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A•T base pairs to G•C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A•T to G•C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A•T base pairs efficiently to G•C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a seventh-generation evolved transfer RNA adenosine deaminase attached to dCas9, researchers demonstrated conversion of A*T base pairs to G*C base pairs in a targeted fashion at efficiencies of around 50% with few undesired mutations in human cells.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Gaudelli et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenine base editor (ABE), first described in 2017, generally does not induce DSBs (<1%) and is therefore a favorable alternative to Cas9 for single and multiplex gene knockouts.12,14”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, these mutations occur significantly more often in human disease than transversion mutations (62% transition vs 38% transversion29,63).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Fusing adenine deaminase (an evolved TadA heterodimer) to a nickase-Cas9 creates an adenine base editor (ABE) that mediates A > G base changes via an inosine intermediate29”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Consistent with the literature1, ABE6.3 resulted in the highest A>G base editing efficiency at position A9 (6.9 ± 2.0%,2 µg ABE6.3) (Supplementary Fig. 1) and editing efficiency was dependent of the ABE enzyme concentration.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Adenine BEs comprise an evolved Escherichia coli TadA (ecTadA*, a tRNA adenosine deaminase evolved to accept DNA substrate) and Cas9 nickase, and mediate A•T to G•C substitutions1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“The ABE editing window occupies positions ~4–9 with the 1st, 5’ nucleotide (nt) of the candidate sgRNA counted as position 1 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Point mutations are a frequent cause of genetic disease, with ~50% of disease point mutations being G:C>A:T 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 896
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Self-citationKim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3803 · Cited by 758
Self-citationA system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 694
Self-citationUracil in DNA – occurrence, consequences and repair
Krokan, H. E., Drabløs, F., & Slupphaug, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205996 · Cited by 500
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,024
Nadakuduti, S. S., Buell, C. R., Voytas, D. F., Starker, C. G., & Douches, D. S. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01607 · Cited by 81
Genome editing methods in animal models
Lee, H., Yoon, D. E., & Kim, K. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1726462 · Cited by 83
Expanding the plant genome editing toolbox with recently developed CRISPR–Cas systems
Wada, N., Osakabe, K., & Osakabe, Y. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac027 · Cited by 83
CRISPR Therapeutics for Duchenne Muscular Dystrophy
Erkut, E. J. N., & Yokota, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031832 · Cited by 82
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
DeJulius, C. R., Walton, B. L., Colazo, J. M., d’Arcy, R., Francini, N., Brunger, J. M., & Duvall, C. L. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01067-4 · Cited by 85
Gu, T., Zhao, S., Pi, Y., Chen, W., Chen, C., Liu, Q., Li, M., Han, D., & Ji, Q. (2018) · Chemical Science · doi:10.1039/c8sc00637g · Cited by 81
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Liu, B., Saber, A., & Haisma, H. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.011 · Cited by 86
Malabarba, J., Chevreau, E., Dousset, N., Veillet, F., Moizan, J., & Vergne, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010319 · Cited by 80
Precise genome-editing in human diseases: mechanisms, strategies and applications
Zheng, Y., Li, Y., Zhou, K., Li, T., VanDusen, N. J., & Hua, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01750-2 · Cited by 91
Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation
Chu, S. H., Packer, M. S., Rees, H. A., Lam, D. K., Yu, Y., Marshall, J., Cheng, L.-I., Lam, D., Olins, J., Ran, F. A., et al. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0144 · Cited by 79
Self-citationGene therapy for cystic fibrosis: new tools for precision medicine
Lee, J. A., Cho, A., Huang, E. N., Xu, Y., Quach, H., Hu, J., & Wong, A. P. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03099-4 · Cited by 94
Multiplex base- and prime-editing with drive-and-process CRISPR arrays
Yuan, Q., & Gao, X. (2022) · Nature Communications · doi:10.1038/s41467-022-30514-1 · Cited by 85
Chen, W., Ma, J., Wu, Z., Wang, Z., Zhang, H., Fu, W., Pan, D., Jin, S. K., & Ji, Q. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.014 · Cited by 80
He, Y., Zhou, X., Chang, C. H., Chen, G., Liu, W., Li, G., Fan, X., Sun, M., Miao, C., Huang, Q., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.01.021 · Cited by 79
Revolutionizing CRISPR technology with artificial intelligence
Kim, M., Go, M.-J., Kang, S.-H., Jeong, S.-H., & Lim, K. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01462-9 · Cited by 87
CRISPR/Cas9-Mediated Adenine Base Editing in Rice Genome
Li, H., Ruiying, Q., Liu, X., Shengxiang, L., Xu, R., Jianbo, Y., & Pengcheng, W. (2019) · Rice Science · doi:10.1016/j.rsci.2018.07.002 · Cited by 78
Li, C., Zong, Y., Jin, S., Zhu, H., Lin, D., Li, S., Qiu, J., Wang, Y., & Gao, C. (2020) · Genome biology · doi:10.1186/s13059-020-02051-x · Cited by 80
Development and Application of CRISPR/Cas in Microbial Biotechnology
Ding, W., Zhang, Y., & Shi, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00711 · Cited by 81
New Plant Breeding Techniques in Citrus for the Improvement of Important Agronomic Traits. A Review
Salonia, F., Ciacciulli, A., Poles, L., Pappalardo, H. D., Malfa, S. G. L., & Licciardello, C. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.01234 · Cited by 84
Synthetic lethal strategies for the development of cancer therapeutics
Ngoi, N. Y. L., Gallo, D., Torrado, C., Nardo, M., Durocher, D., & Yap, T. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00966-z · Cited by 81
Expanding the genome-targeting scope and the site selectivity of high-precision base editors
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2020) · Nature Communications · doi:10.1038/s41467-020-14465-z · Cited by 79
Development and application of CRISPR/Cas9 technologies in genomic editing
Zhang, C., Quan, R., & Wang, J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy120 · Cited by 80
Genotyping genome‐edited mutations in plants using CRISPR ribonucleoprotein complexes
Liang, Z., Chen, K., Yan, Y., Zhang, Y., & Gao, C. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12938 · Cited by 83
Evolution of plant mutagenesis tools: a shifting paradigm from random to targeted genome editing
Shelake, R. M., Pramanik, D., & Kim, J. (2019) · Plant Biotechnology Reports · doi:10.1007/s11816-019-00562-z · Cited by 79
Enabling large-scale genome editing at repetitive elements by reducing DNA nicking
Smith, C. J., Castanon, O., Said, K., Volf, V., Khoshakhlagh, P., Hornick, A., Ferreira, R., Wu, C., Güell, M., Garg, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa239 · Cited by 83
Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture
Kawall, K., Cotter-Howells, J. D., & Then, C. (2020) · Environmental Sciences Europe · doi:10.1186/s12302-020-00361-2 · Cited by 84
Cui, Y., Cao, Q., Li, Y., He, M., & Liu, X. (2023) · Journal of Experimental Botany · doi:10.1093/jxb/erad248 · Cited by 77
Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
Staal, F. J. T., Aiuti, A., & Cavazzana, M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00443 · Cited by 77
Emergent CRISPR–Cas-based technologies for engineering non-model bacteria
Volke, D. C., Orsi, E., & Nikel, P. I. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102353 · Cited by 78
Cheng, P., Mao, C., Tang, J., Yang, S., Cheng, Y., Wang, W., Gu, Q., Han, W., Chen, H., Li, S., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00989-2 · Cited by 76
Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition
Thuy-Boun, A., Thomas, J. M., Mendoza, H. G., Palumbo, C. M., Park, S., Nguyen, L. T., Fisher, A. J., & Beal, P. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa532 · Cited by 75
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy
Mbakam, C. H., Lamothe, G., Tremblay, G., & Tremblay, J. P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01197-9 · Cited by 81
Deep learning models to predict the editing efficiencies and outcomes of diverse base editors
Kim, N., Choi, S.-C., Kim, S., Song, M., Seo, J. H., Min, S., Park, J., Cho, S., & Kim, S. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01792-x · Cited by 78
Haldrup, J., Andersen, S., Labial, A. R. L., Wolff, J. H., Frandsen, F. P., Skov, T. W., Rovsing, A. B., Nielsen, I. H., Jakobsen, T. S., Askou, A. L., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad676 · Cited by 78
Alves, C. R. R., Ha, L. L., Yaworski, R., Sutton, E. R., Lazzarotto, C. R., Christie, K. A., Reilly, A., Beauvais, A., Doll, R. M., de la Cruz, D., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01132-z · Cited by 72
Martyn, G. E., Wienert, B., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2019) · Blood · doi:10.1182/blood-2018-07-863951 · Cited by 75
Reverse Transcriptase: From Transcriptomics to Genome Editing
Martín-Alonso, S., Frutos-Beltrán, E., & Menéndez‐Arias, L. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.06.008 · Cited by 76
Nucleic Acid Databases and Molecular-Scale Computing
Song, X., & Reif, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b02562 · Cited by 73
Coelho, M. A., Li, S., Pane, L. S., Firth, M. A., Ciotta, G., Wrigley, J. D. J., Cuomo, M. E., Maresca, M., & Taylor, B. (2018) · BMC Biology · doi:10.1186/s12915-018-0617-1 · Cited by 75
Zhang, J., Sun, H., Guo, S., Ren, Y., Li, M., Wang, J., Zhang, H., Gong, G., & Xu, Y. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.19.01409 · Cited by 73
Prime Editing: Genome Editing for Rare Genetic Diseases Without Double-Strand Breaks or Donor DNA
Matsoukas, I. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00528 · Cited by 65
Gene Editing by Extracellular Vesicles
Kostyushev, D. S., Kostyusheva, A., Brezgin, S., Vv, S., Volchkova, E. V., Lukashev, A. N., & Chulanov, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197362 · Cited by 75
Untethered Microrobots for Active Drug Delivery: From Rational Design to Clinical Settings
Liu, D., Wang, T., & Lu, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102253 · Cited by 74
Self-citationSystematic optimization of Cas12a base editors in wheat and maize using the ITER platform
Gaillochet, C., Fernández, A. P., Goossens, V., D’Halluin, K., Drozdzecki, A., Shafie, M., Duyse, J. V., Isterdael, G. V., Gonzalez, C., Vermeersch, M., et al. (2023) · Genome biology · doi:10.1186/s13059-022-02836-2 · Cited by 78
Gene editing therapeutics based on mRNA delivery
Popovitz, J., Sharma, R. K., Hoshyar, R., Kim, B. S., Murthy, N., & Lee, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115026 · Cited by 73
Recent application of CRISPR-Cas12 and OMEGA system for genome editing
Badon, I. W., Oh, Y., Kim, H., & Lee, S. H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.11.013 · Cited by 75
Principles of and strategies for germline gene therapy
Wolf, D. P., Mitalipov, P. A., & Mitalipov, S. M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0473-8 · Cited by 75
Li, Q., Sapkota, M., & van der Knaap, E. (2020) · Horticulture Research · doi:10.1038/s41438-020-0258-8 · Cited by 73
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
Lim, K. R. Q., Yoon, C., & Yokota, T. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8040038 · Cited by 75
Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
Song, Y., Liu, Z., Zhang, Y., Chen, M., Sui, T., Lai, L., & Li, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.019 · Cited by 74
Treating Cystic Fibrosis with mRNA and CRISPR
Sanchez, A. D. S., Paunovska, K., Cristian, A., & Dahlman, J. E. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.137 · Cited by 75
Schimmel, J., Muñoz-Subirana, N., Kool, H., van Schendel, R., van der Vlies, S., Kamp, J. A., de Vrij, F. M. S., Kushner, S. A., Smith, G. C. M., Boulton, S. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112019 · Cited by 72
High-throughput evaluation of genetic variants with prime editing sensor libraries
Gould, S. I., Wuest, A. N., Dong, K., Johnson, G. A., Hsu, A., Narendra, V. K., Atwa, O., Levine, S. S., Liu, D. R., & Rivera, F. J. S. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02172-9 · Cited by 73
Self-citationHwang, G., Lee, S., Oh, M., Kim, S., Habib, O., Jang, H., Kim, H. S., Kim, Y., Kim, C. H., Kim, S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01277-5 · Cited by 83
A genome-wide atlas of human cell morphology
Ramezani, M., Weisbart, E., Bauman, J., Singh, A. K., Yong, J., Lozada, M., Way, G. P., Kavari, S. L., Diaz, C., Leardini, E., et al. (2025) · Nature Methods · doi:10.1038/s41592-024-02537-7 · Cited by 74
Li, Q., Li, Y., Yang, S., Huang, S., Yan, M., Ding, Y., Tang, W., Lou, X., Yin, Q., Sun, Z., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0202-4 · Cited by 72
Expanding C–T base editing toolkit with diversified cytidine deaminases
Cheng, T., Li, S., Yuan, B., Wang, X., Zhou, W., & Qiu, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-11562-6 · Cited by 74
Prime Editing: A New Way for Genome Editing
Marzec, M., Brąszewska-Zalewska, A., & Hensel, G. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.004 · Cited by 72
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
Wang, G., Xu, Z., Wang, F., Huang, Y., Xin, Y., Liang, S., Li, B., Si, H., Sun, L., Wang, Q., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01232-3 · Cited by 71
Strategies for In Vivo Genome Editing in Nondividing Cells
Nami, F., Basiri, M., Satarian, L., Curtiss, C., Baharvand, H., & Verfaillie, C. M. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.03.004 · Cited by 73
Microbial Base Editing: A Powerful Emerging Technology for Microbial Genome Engineering
Wang, Y., Liu, Y., Zheng, P., Sun, J., & Wang, M. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.06.010 · Cited by 72
New prospects on the horizon: Genome editing to engineer plants for desirable traits
Iqbal, Z., Iqbal, M. S., Ahmad, A., Memon, A. G., & Ansari, M. I. (2020) · Current Plant Biology · doi:10.1016/j.cpb.2020.100171 · Cited by 70
CRISPR-based metabolic pathway engineering
Zhao, D., Zhu, X., Zhou, H., Sun, N., Wang, T., Bi, C., & Zhang, X. (2020) · Metabolic Engineering · doi:10.1016/j.ymben.2020.10.004 · Cited by 70
Plant Viruses: From Targets to Tools for CRISPR
Varanda, C. M. R., Félix, M. D. R., Campos, M. D., Patanita, M., & Materatski, P. (2021) · Viruses · doi:10.3390/v13010141 · Cited by 70
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Bloomer, H., Khirallah, J., Li, Y., & Xu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114087 · Cited by 75
Hairy CRISPR: Genome Editing in Plants Using Hairy Root Transformation
Kiryushkin, A. S., Ilina, E. L., Guseva, E. D., Pawlowski, K., & Demchenko, K. N. (2021) · Plants · doi:10.3390/plants11010051 · Cited by 70
Novel Plant Breeding Techniques Shake Hands with Cereals to Increase Production
Haroon, M., Zafar, M. M., Farooq, M. A., Afzal, R., Batool, M., Idrees, F., Babar, U., Khan, A. S., 默辉娟, Li, L., et al. (2022) · Plants · doi:10.3390/plants11081052 · Cited by 70
Facioscapulohumeral muscular dystrophy: the road to targeted therapies
Tihaya, M. S., Mul, K., Balog, J., de Greef, J. C., Tapscott, S. J., Tawil, R., Statland, J. M., & van der Maarel, S. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00762-2 · Cited by 70
Cavazza, A., Molina-Estévez, F. J., Reyes, Á. P., Ronco-Díaz, V., Naseem, A., Malenšek, Š., Pečan, P., Santini, A., Heredia, P., Aguilar-González, A., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102457 · Cited by 78
A CRISPR Interference Platform for Efficient Genetic Repression in Candida albicans
Wensing, L. F., Sharma, J., Uthayakumar, D., Proteau, Y., Chavez, A., & Shapiro, R. S. (2019) · mSphere · doi:10.1128/msphere.00002-19 · Cited by 71
De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens
He, W., Zhang, L., Villarreal, O. D., Fu, R., Bedford, E., Dou, J., Patel, A. Y., Bedford, M. T., Shi, X., Chen, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12489-8 · Cited by 69
CRISPR/Cas9 gene-editing strategies in cardiovascular cells
Vermersch, E., Jouve, C., & Hulot, J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz250 · Cited by 74
CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in Bacillus subtilis
Yu, S., Price, M. A., Wang, Y., Liu, Y., Guo, Y., Ni, X., Rosser, S. J., Bi, C., & Wang, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00151 · Cited by 69
Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity
Li, J., Yu, W., Huang, S., Wu, S., Li, L., Zhou, J., Cao, Y., Huang, X., & Qiao, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-22519-z · Cited by 72
CRISPR-based engineering of phages for in situ bacterial base editing
Nethery, M. A., Hidalgo-Cantabrana, C., Roberts, A., & Barrangou, R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206744119 · Cited by 71
Applying multi‐omics toward tumor microbiome research
Zhang, N., Kandalai, S., Zhou, X., Hossain, F., & Zheng, Q. (2023) · iMeta · doi:10.1002/imt2.73 · Cited by 70
Breakthrough in CRISPR/Cas system: Current and future directions and challenges
Ali, A. R., Zafar, M. M., Farooq, Z., Ahmed, S. R., Ijaz, A., Anwar, Z., Abbas, H., Tariq, M. S., Tariq, H., Mustafa, M., et al. (2023) · Biotechnology Journal · doi:10.1002/biot.202200642 · Cited by 69
CRISPR/Cas9 Technology for Enhancing Desirable Traits of Fish Species in Aquaculture
Zhu, M., Sumana, S. L., Muhammad, A. M., Falayi, O. C., Shui, Y., Zhang, C., Zhu, J. X., & Su, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179299 · Cited by 64
Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID
Sasaguri, H., Nagata, K., Sekiguchi, M., Fujioka, R., Matsuba, Y., Hashimoto, S., Sato, K., Kurup, D., Yokota, T., & Saido, T. C. (2018) · Nature Communications · doi:10.1038/s41467-018-05262-w · Cited by 72
Zhang, W., MITCHELL, L. A., Bader, J. S., & Boeke, J. D. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-110704 · Cited by 71
Zhang, E., Neugebauer, M. E., Krasnow, N. A., & Liu, D. R. (2024) · Nature Communications · doi:10.1038/s41467-024-45969-7 · Cited by 68
Self-citationGenetic engineering in organoids
Teriyapirom, I., Batista-Rocha, A. S., & Koo, B.-K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02029-z · Cited by 68
Izmiryan, A., Ganier, C., Bovolenta, M., Schmitt, A., Mavilio, F., & Hovnanian, A. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.008 · Cited by 68
Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses
Liu, A. C., Patel, K., Vunikili, R., Johnson, K. W., Abdu, F., Belman, S. K., Glicksberg, B. S., Tandale, P. P., Fontanez, R., Mathew, O. K., et al. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz059 · Cited by 71
Genome editing technology and application in soybean improvement
Bao, A., Zhang, C., Huang, Y., Chen, H., Zhou, X., & Cao, D. (2020) · Oil Crop Science · doi:10.1016/j.ocsci.2020.03.001 · Cited by 68
In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing
Sinnamon, J. R., Kim, S. Y., Fisk, J. R., Song, Z., Nakai, H., Jeng, S., McWeeney, S. K., & Mandel, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107878 · Cited by 68
Applying gene editing to tailor precise genetic modifications in plants
Eck, J. M. V. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.010850 · Cited by 69
Programmable Live‐Cell CRISPR Imaging with Toehold‐Switch‐Mediated Strand Displacement
Hao, Y., Jiang, L., Li, Q., Zhang, L., Shi, J., Zhang, X., Aldalbahi, A. K., Wang, L., Fan, C., & Wang, F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009062 · Cited by 68
Tran, M. T. N., Khalid, M. K. N. M., Wang, Q., Walker, J. K. R., Lidgerwood, G. E., Dilworth, K. L., Lisowski, L., Pébay, A., & Hewitt, A. W. (2020) · Nature Communications · doi:10.1038/s41467-020-18715-y · Cited by 70
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Rao, S., Yao, Y., & Bauer, D. E. (2021) · Genome Medicine · doi:10.1186/s13073-021-00857-3 · Cited by 72
Directed evolution in mammalian cells
Hendel, S. J., & Shoulders, M. D. (2021) · Nature Methods · doi:10.1038/s41592-021-01090-x · Cited by 68
Harnessing lipid nanoparticles for efficient CRISPR delivery
Yan, J., Kang, D. D., & Dong, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm00537e · Cited by 69
Ravi, N. S., Wienert, B., Wyman, S. K., Bell, H. W., George, A., Mahalingam, G., Vu, J. T., Prasad, K. M., Bandlamudi, B. P., Devaraju, N., et al. (2022) · eLife · doi:10.7554/elife.65421 · Cited by 70
Genome-edited allogeneic donor “universal” chimeric antigen receptor T cells
Qasim, W. (2022) · Blood · doi:10.1182/blood.2022016204 · Cited by 70
Li, Z., Wang, J., Xu, J.-P., Yang, X. F., & Yang, X. F. (2023) · Military Medical Research · doi:10.1186/s40779-023-00447-x · Cited by 72
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
Picco, G., Rao, Y., Saedi, A. A., Lee, Y., Vieira, S. F., Bhosle, S. G., May, K., Herranz, C., Walker, S. J., Shenje≠, R., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0052 · Cited by 72
Genome Editing B.C. (Before CRISPR): Lasting Lessons from the “Old Testament”
Urnov, F. D. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.29007.fyu · Cited by 71
A high‐throughput transient expression system for rice
Page, M. T., Parry, M. A. J., & Carmo‐Silva, E. (2019) · Plant Cell & Environment · doi:10.1111/pce.13542 · Cited by 72
Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors
Lei, Z., Meng, H., Lv, Z., Liu, M., Zhao, H., Wu, H., Zhang, X., Liu, L., Zhuang, Y., Yin, K., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01172-w · Cited by 67
Metadata
- Authors
- Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-11-01
- Volume
- 551
- Issue
- 7681
- Pages
- 464-471
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5726555
- OpenAlex
- W2766599608
- Cited by
- 4,184
- References
- 46
- Citations by year
- 2026: 460 · 2025: 501 · 2024: 521 · 2023: 599 · 2022: 557 · 2021: 489 · 2020: 474 · 2019: 332 · 2018: 237 · 2017: 8
- FWCI
- 117.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-02)
- Open access
- green
- europepmc.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (T32GM008313, F32GM106621, R35GM118062, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adenine base editors, base editing, cytosine deamination, CRISPR/Cas9, directed evolution, protein engineering, transition mutations, point mutations, single nucleotide polymorphisms
- MeSH terms
- Gene Editing, Adenosine Deaminase, DNA, Humans, Models, Molecular, Genome, Human, Base Pairing, Polymorphism, Single Nucleotide, Cell Line, Tumor, DNA Cleavage, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
